Ausgabe 2/2018
Inhalt (11 Artikel)
Towards a New Framework for Addressing Structural Uncertainty in Health Technology Assessment Guidelines
Salah Ghabri, Irina Cleemput, Jean-Michel Josselin
Mepolizumab for Treating Severe Eosinophilic Asthma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Iñigo Bermejo, Matt Stevenson, Katy Cooper, Sue Harnan, Jean Hamilton, Mark Clowes, Christopher Carroll, Tim Harrison, Shironjit Saha
Pomalidomide with Dexamethasone for Treating Relapsed and Refractory Multiple Myeloma Previously Treated with Lenalidomide and Bortezomib: An Evidence Review Group Perspective of an NICE Single Technology Appraisal
Nasuh C. Büyükkaramikli, Saskia de Groot, Debra Fayter, Robert Wolff, Nigel Armstrong, Lisa Stirk, Gill Worthy, Fernando Albuquerque de Almeida, Jos Kleijnen, Maiwenn J. Al
The Assessment for Disinvestment of Intramuscular Interferon Beta for Relapsing-Remitting Multiple Sclerosis in Brazil
Livia Lovato Pires de Lemos, Augusto Afonso Guerra Júnior, Marisa Santos, Carlos Magliano, Isabela Diniz, Kathiaja Souza, Ramon Gonçalves Pereira, Juliana Alvares, Brian Godman, Marion Bennie, Ivan Ricardo Zimmermann, Vânia Crisitna Canuto dos Santos, Clarice Alegre Pretramale, Francisco de Assis Acurcio
Using Latent Class Analysis to Model Preference Heterogeneity in Health: A Systematic Review
Mo Zhou, Winter Maxwell Thayer, John F. P. Bridges
Disease-Modifying Therapies for Multiple Sclerosis: A Systematic Literature Review of Cost-Effectiveness Studies
Sergio Iannazzo, Ange-Christelle Iliza, Louise Perrault
Systematic Review of Validity Assessments of Framingham Risk Score Results in Health Economic Modelling of Lipid-Modifying Therapies in Europe
Jonas Hermansson, Thomas Kahan
Impact of Adverse Events on Health Utility and Health-Related Quality of Life in Patients Receiving First-Line Chemotherapy for Metastatic Breast Cancer: Results from the SELECT BC Study
Yasuhiro Hagiwara, Takeru Shiroiwa, Kojiro Shimozuma, Takuya Kawahara, Yukari Uemura, Takanori Watanabe, Naruto Taira, Takashi Fukuda, Yasuo Ohashi, Hirofumi Mukai
Australian Utility Weights for the EORTC QLU-C10D, a Multi-Attribute Utility Instrument Derived from the Cancer-Specific Quality of Life Questionnaire, EORTC QLQ-C30
Madeleine T. King, Rosalie Viney, A. Simon Pickard, Donna Rowen, Neil K. Aaronson, John E. Brazier, David Cella, Daniel S. J. Costa, Peter M. Fayers, Georg Kemmler, Helen McTaggart-Cowen, Rebecca Mercieca-Bebber, Stuart Peacock, Deborah J. Street, Tracey A. Young, Richard Norman, N. Aaronson, J. Brazier, D. Cella, D. Costa, P. Fayers, P. Grimison, M. Janda, G. Kemmler, M. King (Chair), H. McTaggart-Cowan, R. Mercieca-Bebber, R. Norman, S. Peacock, S. Pickard, D. Rowen, G. Velikova, R. Viney, D. Street, T. Young
Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System
Laura Catherine Edney, Hossein Haji Ali Afzali, Terence Chai Cheng, Jonathan Karnon
Current UK Practices on Health Economics Analysis Plans (HEAPs): Are We Using Heaps of Them?
Melina Dritsaki, Alastair Gray, Stavros Petrou, Susan Dutton, Sarah E. Lamb, Joanna C. Thorn